policy
Singing at the top of your lungs can sometimes be a healthy outlet for relieving your stress. The Undergraduate Student Association at KAIST offers just that. They created coin karaoke kiosks on campus where students can visit and sing their favorite songs across a variety of music genres.
The KAI Coin Karaoke opened near the amphitheater, which consists of five kiosks for one to three people, two booths for six people, and one self-service coin machine. The operation hours are from 12 pm to 2 am, and it costs only 500 KRW for two songs.
“I often enjoy going to a karaoke for singing whenever I feel down and need to let things out,” said Tae-Sik Im, a junior undergraduate of the School of Computing. “Now, I don’t have to leave campus to find a place to sing. It’s much more convenient and safer.”
Many students even squeeze in time to stop by the karaoke during their breaks in between classes and enjoy belting out songs. Afterwards, students confessed, they are in a better mood for class.
“We received a great deal of support from our students during our trial period in February. The facility officially opened on March 20 and anyone can go there and find some time to refresh themselves,” explained Young-Duck Cho, president of KAIST Undergraduate Student Association. He said all proceeds will go to students’ welfare fund. There are three rules to abide by for karaoke users though: no alcohol, no smoking, and no haning out.
(Photo caption:Students sing out at the newly opened KAI Coin Karaoke on the campus.)
-
research Editing Parkinson's Disease – KAIST Makes World's First Discovery of an Inflammatory RNA Editing Enzyme
< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02 -
event KAIST Art Museum Showcases the Works of Van Gogh, Cy Twombly, and More at "The Vault of Masterpieces"
KAIST (President Kwang Hyung Lee) opened a special exhibition "The Vault of Masterpieces" featuring the architects of the Gallerist Hong Gyu Shin, who is active in New York, on April 29th. Since its opening in December 2024, the KAIST Museum of Art, which has mainly exhibited works from its own collection, has boldly invited internationally renowned gallerist Shin Hong-gyu to hold its first full-scale special exhibition, displaying a large number of his collections in the center of the campus
2025-04-30 -
research KAIST sends out Music and Bio-Signs of Professor Kwon Ji-yong, a.k.a. G-Dragon, into Space to Pulsate through Universe and Resonate among Stars
KAIST (President Kwang-Hyung Lee) announced on the 10th of April that it successfully promoted the world’s first ‘Space Sound Source Transmission Project’ based on media art at the KAIST Space Research Institute on April 9th through collaboration between Professor Jinjoon Lee of the Graduate School of Culture Technology, a world-renowned media artist, and the global K-Pop artist, G-Dragon. This project was proposed as part of the ‘AI Entertech Research Center’ be
2025-04-10 -
event KAIST, Galaxy Corporation Hold Signboard Ceremony for ‘AI Entertech Research Center’
KAIST (President Kwang-Hyung Lee) announced on the 9th that it will hold a signboard ceremony for the establishment of the ‘AI Entertech Research Center’ with the artificial intelligence entertech company, Galaxy Corporation (CEO Yong-ho Choi) at the main campus of KAIST. < (Galaxy Corporation, from center to the left) CEO Yongho Choi, Director Hyunjung Kim and related persons / (KAIST, from center to the right) Professor SeungSeob Lee of the Department of Mechanical Engineer
2025-04-09 -
research KAIST Identifies Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening
2025-04-08